Dr. Kundu is an Assistant Professor (Research) at the Department of Urology at University of Arizona College of Medicine, Tucson. Dr. Kundu obtained his M.Tech and Ph.D. from the Indian Institute of Technology Kharagpur in Biotechnology, and molecular biology/biochemistry, respectively. He also pursued a year of fellowship at the National University of Singapore to study active transport across renal proximal cells. During his postdoctoral training (with Dr. Sunil Sudarshan, M.D.) at the University of Alabama at Birmingham, Dr. Kundu studied the molecular understanding of kidney cancer pathobiology in areas like metabolism, signal transduction, and transcription and translation regulation. He was awarded a research fellowship from the American Urological Association, a concept award, and an early career scholar award from the Department of Defense to study semaphorin biology in renal cell carcinoma. Dr. Kundu's independent lab in the Arizona Cancer Center asks fundamental questions related to signal transduction, metabolism, epigenetics, and epitranscriptomics using kidney cancer as a model system. His lab uses various bioinformatics tools, and in vitro and in vivo (mouse) model systems to identify and intervene with druggable axes in ccRCC. Dr. Kundu's long-term goal is to find therapeutic liabilities in ccRCC that can be targeted with the utmost potency using mono-or-combination therapies.